Key Highlights
- Comma launches Sara™, a secure, privacy-first period tracking app to empower reproductive health.
- Raised $2 million in seed funding, with Techstars and women-led investors contributing.
- Sara™ is a progressive web app (PWA) to prevent metadata tracking and ensure user privacy.
- Plans for biodegradable period products and menstrual blood-based diagnostics in development.
- Security-first approach inspired by HIPAA and healthcare best practices.
Source: PR Newswire
Notable Quotes
“Comma is approaching menstrual health in a holistic way that hasn’t been done before in the consumer products and technology space.” — Trey Bowles, Managing Director at Techstars Physical Health
“People shouldn’t have to choose between a better understanding of their bodies and the threat of surveillance.” — Miller Morris, M.A., M.P.H., Founder & CEO at Comma
Why This Matters
With growing concerns about reproductive health privacy in the U.S., Comma’s Sara™ app offers a secure and unbiased platform for period tracking. Unlike traditional apps that may compromise user data, Sara™ prioritizes security with a progressive web app structure that prevents metadata tracking. Additionally, Comma’s commitment to biodegradable period products and menstrual blood diagnostics signals a new era of innovation in reproductive health. By centering women-led investment and expertise, Comma is redefining how technology and sustainability intersect in menstrual healthcare.
